Prevalence and Factors of Non-Vaccination Of Covid-19 in District Peshawar,Khyber Pakhtunkhwa, Pakistan
DOI:
https://doi.org/10.37762/jgmds.10-3.460Keywords:
Non-Vaccination, Vaccine, COVID-19, Prevalence, Pakistan, KnowledgeAbstract
OBJECTIVES
The study aimed to compare the clinical outcome of transverse versus longitudinal incision for surgical release of the first dorsal compartment of the wrist to treat de Quervain’s disease.
METHODOLOGY
In this quasi-experimental study, all the patients with resistant de Quervain’s tenosynovitis who had the surgical release of the first dorsal compartment between January 2008 and December 2020 were included. The surgeries were performed under local anaesthesia. The first dorsal compartment of the wrist was approached through either a longitudinal or transverse incision, and the tendons of the abductor pollicis longus and extensor pollicis brevis were released. Patients were followed for a minimum of three months, and the primary outcome measure was the Visual analogue score (VAS) for relief of pain and secondary outcome measures were any immediate or delayed complications.
RESULTS
98 patients were included in the study with a female-to-male ratio of 7:1. The cohort’s mean age was 44 years (Range 25-75). Most patients were housewives exposed to manual work with the involvement of the dominant hand. There were no major complications besides wound issues and transient paresthesia in few patients. The longitudinal incision was associated with less transient nerve palsies, less duration of surgery and easier identification of structure and anomalies. The only advantage of transverse incision was less scar formation. The clinical outcome was similar in both groups: 94% of patients had complete pain relief (VAS 0).
CONCLUSION
There was no difference in the outcome of de Quervain tenosynovitis when released with a transverse or longitudinal incision. The longitudinal incision had fewer complications as compared to the transverse incision.
Downloads
Metrics
References
Abid K, Bari YA, Younas M, Tahir Javaid S, Imran A. Progress of COVID-19 Epidemic in Pakistan. Asia Pac J Public Health. 2020 May;32(4):154-156 DOI: https://doi.org/10.1177/1010539520927259
Albatineh AN, Dalvand P, Aslani M, Saritas S, Baghi V, Ghanei Gheshlagh R. Prevalence and factors associated with COVID-19 vaccine acceptance among the general population in Asadabad, Iran: a cross-sectional study. Tropical Medicine and Health. 2022 Aug 30;50(1):59 DOI: https://doi.org/10.1186/s41182-022-00453-0
Singh S, Sagar R. A critical look at online survey or questionnaire-based research studies during COVID-19. Asian Journal of Psychiatry. 2021 Nov 1;65:102850. DOI: https://doi.org/10.1016/j.ajp.2021.102850
Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, Haagmans BL, Lauber C, Leontovich AM, Neuman BW, Penzar D. Severe acute respiratory syndrome-related coronavirus: The species and its viruses–a statement of the Coronavirus Study Group. BioRxiv. 2020 Jan 1 DOI: https://doi.org/10.1101/2020.02.07.937862
Wazir MA, Goujon A. Assessing the 2017 census of Pakistan using demographic analysis: A sub-national perspective. Vienna Institute of Demography Working Papers; 2019
Hwang C. Olfactory neuropathy in severe acute respiratory syndrome: report of a case. Acta Neurologica Taiwanica. 2006 Mar 1;15(1):26
de Haro-Licer J, Roura-Moreno J, Vizitiu A, González-Fernández A, González-Ares JA. Long term serious olfactory loss in colds and/or flu. Acta Otorrinolaringologica (English Edition). 2013 Sep 1;64(5):331-8 DOI: https://doi.org/10.1016/j.otoeng.2013.10.004
Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013 Apr;35(2):121-6 DOI: https://doi.org/10.4103/0253-7176.116232
Soomar SM, Soomar SM, Khan M, Moin G, Azam I. COVID-19 vaccine acceptance and hesitancy among the general population of Pakistan: a population-based survey. BMJ open. 2022 Sep 1;12(9):e064096.
Milibari AA. Current situation of coronavirus disease:(COVID-19) review article. Health science journal. 2020:1-4
Magadmi RM, Kamel FO. Beliefs and barriers associated with COVID-19 vaccination among the general population in Saudi Arabia. BMC public health. 2021 Dec;21(1):1-8 DOI: https://doi.org/10.1186/s12889-021-11501-5
Riaz A, Husain S, Yousafzai MT, Nisar I, Shaheen F, Mahesar W, Dal SM, Omer SB, Zaidi S, Ali A. Reasons for non-vaccination and incomplete vaccinations among children in Pakistan. Vaccine. 2018 Aug 23;36(35):5288-93 DOI: https://doi.org/10.1016/j.vaccine.2018.07.024
Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia. Frontiers in public health. 2020 Jul 14;8:381 DOI: https://doi.org/10.3389/fpubh.2020.00381
Chaudhary FA, Ahmad B, Khalid MD, Fazal A, Javaid MM, Butt DQ. Factors influencing COVID-19 vaccine hesitancy and acceptance among the Pakistani population. Human vaccines & immunotherapeutics. 2021 Oct 3;17(10):3365-70 DOI: https://doi.org/10.1080/21645515.2021.1944743
Chan EY, Cheng CK, Tam GC, Huang Z, Lee PY. Willingness of future A/H7N9 influenza vaccine uptake: a cross-sectional study of Hong Kong community. Vaccine. 2015 Sep 11;33(38):4737-40 DOI: https://doi.org/10.1016/j.vaccine.2015.07.046
Pollard AJ, Launay O, Lelievre JD, Lacabaratz C, Grande S, Goldstein N, Robinson C, Gaddah A, Bockstal V, Wiedemann A, Leyssen M. Safety and immunogenicity of a two-dose heterologous Ad26. ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases. 2021 Apr 1;21(4):493-506
Oliveira BL, Campos MA, Queiroz RC, Souza BF, Santos AM, Silva AA. Prevalence and factors associated with covid-19 vaccine hesitancy in Maranhão, Brazil. Revista de Saúde Pública. 2021 Apr 23;55:12 DOI: https://doi.org/10.11606/s1518-8787.2021055003903err
Bahl K, Senn JJ, Yuzhakov O, Bulychev A, Brito LA, Hassett KJ, Laska ME, Smith M, Almarsson Ö, Thompson J, Ribeiro AM. Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Molecular Therapy. 2017 Jun 7;25(6):1316-27 DOI: https://doi.org/10.1016/j.ymthe.2017.03.035
Scherpenisse M, Mollers M, Schepp RM, Meijer CJ, de Melker HE, Berbers GA, van der Klis FR. Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination. Human vaccines & immunotherapeutics. 2013 Feb 1;9(2):314-21 DOI: https://doi.org/10.4161/hv.22693
Rahman A, Ikram M, Arif A, Khan B, Azam K, Fida M, Rahim A, Khan M, Mushtaq M, Fida R, Yunus H. Prevalence and difference of COVID-19 symptoms, post-COVID conditions and duration of illness among the vaccinated and unvaccinated population: a cross-sectional study in Peshawar. Annals of Medicine and Surgery (2012). 2023 Apr 10;85(5):1678-84 DOI: https://doi.org/10.1097/MS9.0000000000000606
Khan ZA, Allana R, Afzal I, Ali AS, Mariam O, Aslam R, Shah IA, Allana A, Haider MM, Jandani R, Khan Z. Assessment of attitude and hesitancy toward vaccine against COVID-19 in a Pakistani population: A mix methods survey. Vacunas. 2022 May 1;23:S26-32 DOI: https://doi.org/10.1016/j.vacun.2021.08.002
Soomar SM, Soomar SM, Khan M, Moin G, Azam I. COVID-19 vaccine acceptance and hesitancy among the general population of Pakistan: a population-based survey. BMJ open. 2022 Sep 1;12(9):e064096 DOI: https://doi.org/10.1136/bmjopen-2022-064096
Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey. Journal of multidisciplinary healthcare. 2020 Nov 20:1657-63 DOI: https://doi.org/10.2147/JMDH.S276771
Guay M, Maquiling A, Chen R, Lavergne V, Baysac DJ, Racine A, Dubé E, MacDonald SE, Gilbert NL. Measuring inequalities in COVID-19 vaccination uptake and intent: results from the Canadian Community Health Survey 2021. BMC Public Health. 2022 Dec;22(1):1-6 DOI: https://doi.org/10.1186/s12889-022-14090-z
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Inam Ullah, Raheela Bahar
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.